ABIVAX: cashflow_financing
| Value | {"amount": 82679000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | ABIVAX |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:11:47.099859+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/dcf1c79c-8124-4e4e-ad26-831d7285745d
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500D8TMNB184OJU95:2023-12-31Retrieved: 2026-08-24T00:11:47.099859+02:00
Raw response sha256:
946b692566be1267bf3e1b12f850587d…Cite as: FACTANKER, https://factanker.com/fact/dcf1c79c-8124-4e4e-ad26-831d7285745d
History
- no predecessors — first report